Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

BACKGROUND: Inflammation has been associated with increased morbidity and mortality in HIV-positive patients. We compared inflammatory biomarkers with dual therapy using lopinavir/ritonavir plus lamivudine (LPV/r+3TC) versus triple therapy using LPV/r plus two nucleoside reverse transcriptase inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Tan, Darrell H. S., Rolon, Maria Jose, Figueroa, Maria Ines, Sued, Omar, Gun, Ana, Kaul, Rupert, Raboud, Janet M., Szadkowski, Leah, Hull, Mark W., Walmsley, Sharon L., Cahn, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6730918/
https://ncbi.nlm.nih.gov/pubmed/31490959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0221653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados